Siga Technologies (SIGA) Operating Margin (2010 - 2025)
Siga Technologies' (SIGA) quarterly Operating Margin came in at 390.17% in Q3 2025, down 39559.0% on a YoY basis from N/an in Q3 2024, and down 792.89% quarter-over-quarter from 56.31% in Q2 2025.
Powered by 
Analysis
Siga Technologies (SIGA) Operating Margin (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Operating Margin for 16 consecutive years, with 390.17% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Operating Margin fell 39559.0% year-over-year to 390.17%; the trailing twelve-month figure through Sep 2025 stood at 52.42% (down 778.0% YoY), and the FY2024 full-year result was 50.45%, down 932.0% from the prior year.
- Operating Margin slipped to 390.17% in Q3 2025 per SIGA's latest filing, from 56.31% in the prior quarter.
- Across five years, Operating Margin topped out at 81.51% in Q4 2021 and bottomed at 390.17% in Q3 2025.
- Historically, Operating Margin has averaged 13.32% across 5 years, with a median of 0.01% in 2021.
- The sharpest annual moves came in 2022 and 2025: Operating Margin surged 12012 bps in 2022, then slumped 39559 bps in 2025.
- Over 5 years, Operating Margin stood at 81.51% in 2021, then tumbled by 119 bps to 15.89% in 2022, then jumped by 595 bps to 78.71% in 2023, then retreated by 11 bps to 70.07% in 2024, then plunged by 657 bps to 390.17% in 2025.
- According to Business Quant data, Operating Margin over the past three periods registered 390.17%, 56.31%, and 32.03% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 32.97% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 28.37% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 9.03% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 41.69% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.23% |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -390.17% |
| Jun 30, 2025 | 56.31% |
| Mar 31, 2025 | -32.03% |
| Dec 31, 2024 | 70.07% |
| Sep 30, 2024 | 5.42% |
| Jun 30, 2024 | 4.95% |
| Mar 31, 2024 | 44.34% |
| Dec 31, 2023 | 78.71% |
| Sep 30, 2023 | -14.18% |
| Jun 30, 2023 | -78.91% |
| Mar 31, 2023 | -25.33% |
| Dec 31, 2022 | -15.89% |
| Sep 30, 2022 | 59.37% |
| Jun 30, 2022 | 18.42% |
| Mar 31, 2022 | -13.65% |
| Dec 31, 2021 | 81.51% |
| Sep 30, 2021 | -60.75% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | -41.33% |
| Dec 31, 2020 | 71.04% |